Company intelligence / Profile preview

Silver Lake

Monrovia, California, United Statessilverlake.com ↗

Ownership: Private
Development stage: Other

Overview

Silver Lake Research develops and manufactures rapid point-of-care diagnostic kits using EAP™ monoclonal antibodies. Their products are known for high sensitivity and accuracy, matching or surpassing laboratory assays. They offer commercialized test kits for water contaminants, bacteria, lead, radon, asbestos, and other health-related applications[1][4][5].

Therapeutic areas: OtherInfectious Diseases
Modalities: Monoclonal antibodyLateral flow assayPoint-of-care diagnostics
Industry: Protein Biomarker Diagnostics

Beyond the preview

Go deeper on Silver Lake.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Silver Lake.

Explore the full profile